67 related articles for article (PubMed ID: 21670474)
1. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.
Schmitz M; Breithaupt P; Scheidegger N; Cario G; Bonapace L; Meissner B; Mirkowska P; Tchinda J; Niggli FK; Stanulla M; Schrappe M; Schrauder A; Bornhauser BC; Bourquin JP
Blood; 2011 Aug; 118(7):1854-64. PubMed ID: 21670474
[TBL] [Abstract][Full Text] [Related]
2. Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support.
Boutter J; Huang Y; Marovca B; Vonderheit A; Grotzer MA; Eckert C; Cario G; Wollscheid B; Horvath P; Bornhauser BC; Bourquin JP
Oncotarget; 2014 Nov; 5(22):11501-12. PubMed ID: 25415224
[TBL] [Abstract][Full Text] [Related]
3. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of structural variants in single cells using Strand-seq.
Jeong H; Grimes K; Rauwolf KK; Bruch PM; Rausch T; Hasenfeld P; Benito E; Roider T; Sabarinathan R; Porubsky D; Herbst SA; Erarslan-Uysal B; Jann JC; Marschall T; Nowak D; Bourquin JP; Kulozik AE; Dietrich S; Bornhauser B; Sanders AD; Korbel JO
Nat Biotechnol; 2023 Jun; 41(6):832-844. PubMed ID: 36424487
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing.
Chen GM; Chen CH; Perazzelli J; Grupp SA; Barrett DM; Tan K
Cancer Immunol Res; 2023 Jan; 11(1):13-19. PubMed ID: 36255409
[TBL] [Abstract][Full Text] [Related]
6. Reversal of
Butler M; Vervoort BMT; van Ingen Schenau DS; Jongeneel L; van der Zwet JCG; Marke R; Meijerink JPP; Scheijen B; van der Meer LT; van Leeuwen FN
Front Oncol; 2022; 12():905665. PubMed ID: 36119546
[TBL] [Abstract][Full Text] [Related]
7. LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance.
Michalek S; Goj T; Plazzo AP; Marovca B; Bornhauser B; Brunner T
EMBO Rep; 2022 Sep; 23(9):e54195. PubMed ID: 35801407
[TBL] [Abstract][Full Text] [Related]
8. Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.
Benard BA; Leak LB; Azizi A; Thomas D; Gentles AJ; Majeti R
Nat Commun; 2021 Dec; 12(1):7244. PubMed ID: 34903734
[TBL] [Abstract][Full Text] [Related]
9. Efficient Generation of Multi-gene Knockout Cell Lines and Patient-derived Xenografts Using Multi-colored Lenti-CRISPR-Cas9.
Behrmann L; McComb S; Aguadé-Gorgorió J; Huang Y; Hermann M; Pelczar P; Aguzzi A; Bourquin JP; Bornhauser BC
Bio Protoc; 2017 Apr; 7(7):e2222. PubMed ID: 34541223
[TBL] [Abstract][Full Text] [Related]
10. BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway.
Butler M; van Ingen Schenau DS; Yu J; Jenni S; Dobay MP; Hagelaar R; Vervoort BMT; Tee TM; Hoff FW; Meijerink JP; Kornblau SM; Bornhauser B; Bourquin JP; Kuiper RP; van der Meer LT; van Leeuwen FN
Blood; 2021 Dec; 138(23):2383-2395. PubMed ID: 34280258
[TBL] [Abstract][Full Text] [Related]
11. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
[TBL] [Abstract][Full Text] [Related]
12. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
13. TNFR2 is required for RIP1-dependent cell death in human leukemia.
Aguadé-Gorgorió J; McComb S; Eckert C; Guinot A; Marovca B; Mezzatesta C; Jenni S; Abduli L; Schrappe M; Dobay MP; Stanulla M; von Stackelberg A; Cario G; Bourquin JP; Bornhauser BC
Blood Adv; 2020 Oct; 4(19):4823-4833. PubMed ID: 33027529
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors.
Erarslan-Uysal B; Kunz JB; Rausch T; Richter-Pechańska P; van Belzen IA; Frismantas V; Bornhauser B; Ordoñez-Rueada D; Paulsen M; Benes V; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Loukanov T; Gorenflo M; Waszak SM; Bourquin JP; Muckenthaler MU; Korbel JO; Kulozik AE
EMBO Mol Med; 2020 Sep; 12(9):e12104. PubMed ID: 32755029
[TBL] [Abstract][Full Text] [Related]
15. Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia.
Gauert A; Olk N; Pimentel-Gutiérrez H; Astrahantseff K; Jensen LD; Cao Y; Eggert A; Eckert C; Hagemann AIH
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32668722
[TBL] [Abstract][Full Text] [Related]
16. Repurposing anthelmintic agents to eradicate resistant leukemia.
Mezzatesta C; Abduli L; Guinot A; Eckert C; Schewe D; Zaliova M; Vinti L; Marovca B; Tsai YC; Jenni S; Aguade-Gorgorio J; von Stackelberg A; Schrappe M; Locatelli F; Stanulla M; Cario G; Bourquin JP; Bornhauser BC
Blood Cancer J; 2020 Jun; 10(6):72. PubMed ID: 32591499
[TBL] [Abstract][Full Text] [Related]
17. Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
Alruwetei AM; Bendak K; Yadav BD; Carol H; Evans K; Mayoh C; Sutton R; Marshall GM; Lock RB
Br J Cancer; 2020 Sep; 123(5):742-751. PubMed ID: 32536690
[TBL] [Abstract][Full Text] [Related]
18. Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.
Somers K; Evans K; Cheung L; Karsa M; Pritchard T; Kosciolek A; Bongers A; El-Ayoubi A; Forgham H; Middlemiss S; Mayoh C; Jones L; Gupta M; Kees UR; Chernova O; Korotchkina L; Gudkov AV; Erickson SW; Teicher B; Smith MA; Norris MD; Haber M; Lock RB; Henderson MJ
Leukemia; 2020 Jun; 34(6):1524-1539. PubMed ID: 31848452
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
Harrop R; O'Neill E; Stern PL
Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
[TBL] [Abstract][Full Text] [Related]
20. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia.
Richter-Pechańska P; Kunz JB; Bornhauser B; von Knebel Doeberitz C; Rausch T; Erarslan-Uysal B; Assenov Y; Frismantas V; Marovca B; Waszak SM; Zimmermann M; Seemann J; Happich M; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Muckenthaler MU; Korbel JO; Bourquin JP; Kulozik AE
EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30389682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
